Taro Pharmaceutical Industries Ltd (TARO) - Financial and Strategic SWOT Analysis Review - Product Image

Taro Pharmaceutical Industries Ltd (TARO) - Financial and Strategic SWOT Analysis Review

  • ID: 4372856
  • SWOT Analysis
  • 44 pages
  • GlobalData
  • Taro Pharmaceutical Industries Ltd
1 of 5

FEATURED COMPANIES

  • Bayer Inc
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • Hoffmann-La Roche Inc
  • Novartis AG
  • Perrigo Company Plc
  • MORE
Taro Pharmaceutical Industries Ltd (TARO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Taro Pharmaceutical Industries Ltd (Taro), a subsidiary of Sun Pharmaceutical Industries Ltd, research develops and markets healthcare products. The company manufactures prescription drugs, nonprescription drugs and active pharmaceutical ingredients (APIs). It develops pharmaceutical products in various dosage forms including semi-solids formulations, such as ointments and creams and other dosage forms which include liquids, capsules and tablets. Taro focuses on major therapeutic areas which include dermatological and topical, neuropsychiatric, anti-inflammatory and cardiovascular. The company sells and distributes its product to healthcare institutions, drug store chains, and private pharmacies. It has presence in Israel, the US, Canada and other countries. Taro is headquartered in Haifa Bay, Israel.

Taro Pharmaceutical Industries Ltd Key Recent Developments

Aug 08,2017: Taro Provides Results for Quarter Ended June 2017
May 22,2017: Taro Provides Results for Year Ended March 31, 2017
Feb 09,2017: Taro Provides Results for December 31, 2016
Dec 01,2016: Taro Pharmaceutical appoints new interim CEO
Dec 01,2016: Taro Announces Appointment of Interim CEO

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Bayer Inc
  • Eli Lilly and Company
  • GlaxoSmithKline Plc
  • Hoffmann-La Roche Inc
  • Novartis AG
  • Perrigo Company Plc
  • MORE
Section 1 - About the Company
  • Taro Pharmaceutical Industries Ltd - Key Facts
  • Taro Pharmaceutical Industries Ltd - Key Employees
  • Taro Pharmaceutical Industries Ltd - Key Employee Biographies
  • Taro Pharmaceutical Industries Ltd - Major Products and Services
  • Taro Pharmaceutical Industries Ltd - History
  • Taro Pharmaceutical Industries Ltd - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Taro Pharmaceutical Industries Ltd - Business Description
  • Taro Pharmaceutical Industries Ltd - SWOT Analysis
  • SWOT Analysis - Overview
  • Taro Pharmaceutical Industries Ltd - Strengths
  • Taro Pharmaceutical Industries Ltd - Weaknesses
  • Taro Pharmaceutical Industries Ltd - Opportunities
  • Taro Pharmaceutical Industries Ltd - Threats
  • Taro Pharmaceutical Industries Ltd - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Taro Pharmaceutical Industries Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • May 22, 2017: Taro Provides Results for Year Ended March 31, 2017
  • Feb 09, 2017: Taro Provides Results for December 31, 2016
  • Dec 01, 2016: Taro Pharmaceutical appoints new interim CEO
  • Dec 01, 2016: Taro Announces Appointment of Interim CEO
  • Nov 22, 2016: Taro Pharmaceutical announces management changes
  • Nov 22, 2016: Taro Announces Appointment of New CEO and New Board Member Nominations
  • Nov 08, 2016: Taro Provides Results for September 30, 2016
  • Oct 26, 2016: TARO SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline
  • Oct 03, 2016: Taro Appoints New Chief Financial Officer
  • Aug 10, 2016: Taro Provides Results for Quarter Ended June 2016
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Taro Pharmaceutical Industries Ltd, Key Facts
  • Taro Pharmaceutical Industries Ltd, Key Employees
  • Taro Pharmaceutical Industries Ltd, Key Employee Biographies
  • Taro Pharmaceutical Industries Ltd, Major Products and Services
  • Taro Pharmaceutical Industries Ltd, History
  • Taro Pharmaceutical Industries Ltd, Subsidiaries
  • Taro Pharmaceutical Industries Ltd, Key Competitors
  • Taro Pharmaceutical Industries Ltd, Ratios based on current share price
  • Taro Pharmaceutical Industries Ltd, Annual Ratios
  • Taro Pharmaceutical Industries Ltd, Annual Ratios (Cont...1)
  • Taro Pharmaceutical Industries Ltd, Annual Ratios (Cont...2)
  • Taro Pharmaceutical Industries Ltd, Interim Ratios
  • Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
  • Taro Pharmaceutical Industries Ltd, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Taro Pharmaceutical Industries Ltd, Performance Chart (2013 - 2017)
  • Taro Pharmaceutical Industries Ltd, Ratio Charts
  • Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
  • Taro Pharmaceutical Industries Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Teva Pharmaceutical Industries Ltd
  • Rafa Laboratories Ltd
  • Perrigo Company Plc
  • Novartis AG
  • Hoffmann-La Roche Inc
  • Hayat Pharmaceutical Industries
  • GlaxoSmithKline Plc
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company
  • Bayer Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll